BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1832654)

  • 1. Hirudin--a potential stabilizing factor for platelet preservation in transfusion.
    Pindur G; Wenzel E; Koehler M; Heiden M; Braun B
    Haemostasis; 1991; 21 Suppl 1():156-60. PubMed ID: 1832654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage.
    Shanwell A; Falker C; Gulliksson H
    Vox Sang; 2003 Oct; 85(3):206-12. PubMed ID: 14516451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin effects of native and recombinant hirudins.
    Markwardt F; Stürzebecher J; Glusa E
    Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
    Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet functions in recombinant hirudin-anticoagulated blood.
    Glusa E; Markwardt F
    Haemostasis; 1990; 20(2):112-8. PubMed ID: 2363746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of recombinant hirudin on various platelet functions.
    Basic-Micic M; Rauschenbach C; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():107-15. PubMed ID: 1894185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
    Kouz J; Czech J; Nicolay U; Dickneite G
    Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
    Blombäck M; Chmielewska J; Netré C; Akerblom O
    Vox Sang; 1984; 47(5):335-42. PubMed ID: 6209855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.
    Mirshahi M; Soria J; Soria C; Faivre R; Lu H; Courtney M; Roitsch C; Tripier D; Caen JP
    Blood; 1989 Aug; 74(3):1025-30. PubMed ID: 2502207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of thrombin inhibitors and aprotinin in the preservation of platelets stored for transfusion.
    Bode AP; Miller DT
    J Lab Clin Med; 1989 Jun; 113(6):753-8. PubMed ID: 2471765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
    Kaplan KL; Drillings M; Lesznik G
    J Clin Invest; 1981 May; 67(5):1561-8. PubMed ID: 6453136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the thrombin-platelet reaction by hirudin.
    Hoffmann A; Markwardt F
    Haemostasis; 1984; 14(2):164-9. PubMed ID: 6735274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of in vitro function of platelets stored in the presence of inhibitors of platelet activation and a specific inhibitor of thrombin.
    Bode AP; Miller DT
    J Lab Clin Med; 1988 Jan; 111(1):118-24. PubMed ID: 3335821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques.
    Dugan G; O'Donnell L; Hanbury DB; Cline JM; Caudell DL
    Platelets; 2015; 26(8):730-5. PubMed ID: 25549285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of platelet concentrates with the new Dideco blood cell separator: Excel.
    Schooneman F
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():130-4. PubMed ID: 8013971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activity during storage of platelets in plasma.
    Wallvik J; Suontaka AM; Blombäck M
    Transfus Med; 1992 Jun; 2(2):135-42. PubMed ID: 1308210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.